Milana Dolezal in Stanford, California

Home California Stanford

Milana Dolezal has Hematology/oncology as her primary medical specialty. Their primary office is: 300 Pasteur Dr in Stanford, California.

They're a part of the: Stanford Health Care medical group which has around 2,603 members. You can call their office at 650-723-4000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Jefferson Medical College Of Thomas Jefferson University and graduated in 1999 (around 25 years of experience). They are listed as doing telehealth appointments.

Milana V Dolezal Office Phone and Directions

Milana Dolezal
Stanford Health Care
300 Pasteur Dr
Stanford, California 94305
650-723-4000

Patient Ratings
Please rate your experience with Milana Dolezal below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 650-723-4000

Enter a starting address:

Healthcare Info for Milana Dolezal

Additional Medical Specialties Include:
MEDICAL ONCOLOGY

Medical School: Jefferson Medical College Of Thomas Jefferson University
Graduation Year: 1999
The Primary Medical Specialty for Milana Dolezal is listed as: Hematology/oncology
Approximate Years of Experience: 25
PAC (PECOS ID)#: 3678634615
NPI #: 1174777643
NPI Created On: 11/11/2008
NPI Last Updated Listed as: 02/21/2022
Primary Taxonomy Code: 174400000X
License Number:
A74043
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Russian, Mandarin, Czech.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of drug or substance into a vein for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Application of on-body injector for injection under skin
Infusion of chemotherapy into a vein up to 1 hour
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Prolonged patient service without direct patient contact first hour
Physician telephone patient service, 21-30 minutes of medical discussion
Injection, denosumab, 1 mg
Injection, dexamethasone sodium phosphate, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787958369

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787958371

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787958373

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545061

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545063

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545065

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545067

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545069

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545073

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545071

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Hematology/oncology Professionals in Stanford

1.
Hitomi Hosoya

300 Pasteur Dr
Stanford, CA
Stanford Health Care

2.
Frank Stockdale

300 Pasteur Dr
Stanford, CA
Stanford Health Care

3.
Ali Khaki

300 Pasteur Dr
Stanford, CA
Stanford Health Care

4.
Gabriel Mannis

300 Pasteur Dr
Stanford, CA
Stanford Health Care

5.
Kim Son Nguyen

300 Pasteur Dr
Stanford, CA
Stanford Health Care

6.
Lawrence Leung

300 Pasteur Dr
Stanford, CA
Stanford Health Care

Providers in Stanford Health Care

1.Oliver Aalami

300 Pasteur Dr
Stanford Ca 94305-2200
Stanford Health Care
Vascular Surgery

2.Sumaira Aasi

420 Broadway St
Redwood City Ca 94063-3132
Stanford Health Care
Dermatology

3.Sumaira Aasi

450 Broadway St
Redwood City Ca 94063-3132
Stanford Health Care
Dermatology

4.Sumaira Aasi

300 Pasteur Dr
Stanford Ca 94305-2200
Stanford Health Care
Dermatology

5.Fahim Abbasi

300 Pasteur Dr
Stanford Ca 94305-2200
Stanford Health Care
Internal Medicine

6.Steven Abboud

300 Pasteur Dr
Stanford Ca 94305-2200
Stanford Health Care
Anesthesiology

View all 2,603 members of Stanford Health Care medical group